Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, OTC and biosimilar products around the world.
Our future strategy relies heavily on our strategic selection of people and successful global parterships.
A unique portfolio of high-quality and difficult-to-make products fuels our targeted growth strategy.
Follow news and programs from Alvogen around the world as they unfold.
Alvogen has commercial operations in 35 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.